2022
The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer
Kevin H. Kensler, Shakuntala Baichoo, Shailja Pathania, and Timothy R. Rebbeck (2022), NPJ Precision Oncology
DOI: https://doi.org/10.1038/s41698-022-00284-6
2021
Ye He, Joshua Rivera, Miklos Diossy, Haohui Duan, Christian Bowman-Colin, Rachel Reed, Rebecca Jennings, Jesse Novak, Stevenson V. Tran, Elizabeth F. Cohen, View ORCID ProfileDavid Szuts, Anita Giobbie-Hurder, Roderick T. Bronson, Adam J. Bass, Sabina Signoretti, Zoltan Szallasi, David M. Livingston, and Shailja Pathania (2021), PNAS
PNAS October 12, 2021 118 (41) e2108421118; https://doi.org/10.1073/pnas.2108421118
2020
RPA, RFWD3, and BRCA2 at stalled forks: a balancing act
Haohui Duan & Shailja Pathania (2020), Molecular & Cellular Oncology
DOI: 10.1080/23723556.2020.1801089
Zervantonakis IK, Poskus MD, Scott AL, Selfors LM, Lin JR, Dillon DA, Pathania S, Sorger PK, Mills GB, Brugge JS.Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16500-16508. Epub 2020 Jun 29.PMID: 32601199
DOI: 10.1073/pnas.2000648117
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells.
Duan H, Mansour S, Reed R, Gillis MK, Parent B, Liu B, Sztupinszki Z, Birkbak N, Szallasi Z, Elia AEH, Garber JE, Pathania S. J Cell Biol. 2020 Jun 1;219(6):e201908192. doi: 10.1083/jcb.201908192.
2019
Maertens O, Kuzmickas R, Manchester HE, Emerson CE, Gavin AG, Guild CJ, Wong TC, De Raedt T, Bowman-Colin C, Hatchi E, Garraway LA, Flaherty KT, Pathania S, Elledge SJ, Cichowski K.Cancer Discov. 2019 Apr;9(4):526-545. doi: 10.1158/2159-8290.CD-18-0879. Epub 2019 Feb 1.
2018
Pathania S., Garber JE. J Natl Cancer Inst. 2018 Sep 1;110(9):925-926. doi: 10.1093/jnci/djy047.
Birkbak NJ*, Li Y*, Pathania S*, Greene-Colozzi A, Dreze M, Bowman-Colin C, Sztupinszki Z, Krzystanek M, Diossy M, Tung N, Ryan PD, Garber JE, Silver DP, Iglehart JD, Wang ZC, Szuts D, Szallasi Z, Richardson AL. *Equal contribution. (2018) Ann Oncol. doi:10.1093/annonc/mdy049.
2016
Hua Wang, Brian Bierie, Andrew G. Li, Shailja Pathania, Kimberly Toomire, Stoil D Dimitrov, Ben Liu, Rebecca Gelman, Anita Giobbie-Hurder, Jean Feunteun, Kornelia Polyak, and David M. Livingston. Mol Cell. 2016 July 21; 63(2): 277–292.
2015
BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair.
Hatchi E, Skourti-Stathaki K, Ventz S, Pinello L, Yen A, Kamieniarz-Gdula K, Dimitrov S, Pathania S, McKinney KM, Eaton ML, Kellis M, Hill SJ, Parmigiani G, Proudfoot NJ, Livingston DM. Mol Cell. 2015 Feb19; 57(4):636-47 . doi: 10.1016/j.mol cel. 2015.01.011.
2014
BRCA1 haploinsufficiency for replication stress suppression in primary cells.
Pathania S*, Bade S, Le Guillou M, Burke K, Reed R, Bowman-Colin C, Su Y, Ting DT, Polyak K, Richardson AL, Feunteun J, Garber JE, Livingston DM*. Nature Communication. 2014 Nov 17;5:5496. doi: 10.1038/ncomms6496. *co-senior authors.
2013
Dimitrov SD, Lu D, Naetar N, Hu Y, Pathania S, Kanellopoulou C, Livingston DM. . Genes Dev. 2013 Oct 15;27(20):2274-91. doi: 10.1101/gad.225045.113.
2011
BRCA1 is required for postreplication repair after UV-induced DNA damage.
Pathania S, Nguyen J, Hill SJ, Scully R, Adelmant GO, Marto JA, Feunteun J, Livingston DM. Mol Cell. 2011 Oct 21;44(2):235-51. doi: 10.1016/j.molcel.2011.09.002. Epub 2011 Sep 29.
2009
Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.
Johnson N, Cai D, Kennedy RD, Pathania S, Arora M, Li YC, D’Andrea AD, Parvin JD, Shapiro GI. . Mol Cell. 2009 Aug 14;35(3):327-39. doi: 10.1016/j.molcel.2009.06.036.
2006
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.
Greenberg RA, Sobhian B, Pathania S, Cantor SB, Nakatani Y, Livingston DM. Genes Dev. 2006 Jan 1;20(1):34-46